11/23/2022 1:23:00 PM | less than a minute read

To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines

Get in touch

Guillaume de Villegas

Counsel

Get in touch

Guillaume de Villegas

Counsel

Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders. Last week the CJEU published its keenly awaited judgments concerning several well-known pharmaceutical companies which provide welcome guidance. Read the article in full on BioTalk here.

When marketing meets GenAI: update – What do the final EU AI Act transparency guidelines and code of practice mean for advertisers?

By Nick Aries Quinn Liang Charlotte Autissier

7/26/2026 9:00:07 AM

There Is ‘Rice’ On Venus: The VENERE Trade Mark Serves Up a Lesson For Brand Owners

By Sara Consorti

7/21/2026 10:52:48 AM

IP protection strategies combatting rise of deepfakes: Taylor Swift joins growing trend

By Ann Henry Sarah McMullen Isabel Humburg

6/22/2026 6:17:53 PM

Interesting decision by the German Federal Patent Court (Bundespatentgericht) on geographical indications (GIs)

By Niklas Fels

BrandWrites

To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines

Get in touch

Get in touch

Tags

Get in touch

Get in touch

Latest Insights

When marketing meets GenAI: update – What do the final EU AI Act transparency guidelines and code of practice mean for advertisers?

There Is ‘Rice’ On Venus: The VENERE Trade Mark Serves Up a Lesson For Brand Owners

IP protection strategies combatting rise of deepfakes: Taylor Swift joins growing trend

Interesting decision by the German Federal Patent Court (Bundespatentgericht) on geographical indications (GIs)